Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2003
08/12/2003US6605753 Transgenic mouse with increased insulin sensitivity; resistance to weight gain when fed a high fat, high carbohydrate diet
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/12/2003US6605710 Gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
08/12/2003US6605701 Insecticidal protein against the Western corn rootworm
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605469 Vector ligated to regulatory sequence for gene expression
08/12/2003US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
08/12/2003US6605466 Glycated collagen and fibroblasts
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605458 Subtilase enzyme with insertion in active loop; wash detergents
08/12/2003US6605457 Influenza vaccine
08/12/2003US6605456 Nucleic acids encoding IKR-2, a protein kinase related to the I kappa B kinases
08/12/2003US6605454 Microfluidic devices with monolithic microwave integrated circuits
08/12/2003US6605449 Saturation mutagenesis to produce progenitor polynucleotide library
08/12/2003US6605443 Drug screening for compound which disrupts Smad7 transforming growth-beta factor superfamily signal transduction inhibitory activity
08/12/2003US6605433 Mitochondrial dosimeter
08/12/2003US6605430 Genetic engineering to produce library of polynucleotides encoding polypeptides; screening, recovering
08/12/2003US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
08/12/2003US6605280 Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18
08/12/2003US6605275 Growing in vitro human neonatal or fetal hematopoietic stem cells from umbilical cord or placental blood collected at birth, introducing into human patient effective amount of progeny stem cells for hematopoietic reconstitution
08/12/2003US6605271 Activating cell proliferation and differentiation in hematopoietic cells; obtain cells, incubate with modulator, monitor cell propagation
08/12/2003CA2348132C A system for cell-based screening
08/12/2003CA2264441C Methods for determining the biocompability of lipophilic substances in cell culture tests using nanoemulsions
08/12/2003CA2248653C Vaccines for treatment of lymphoma and leukemia
08/12/2003CA2223155C Secretion leader trap cloning method
08/07/2003WO2003065042A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
08/07/2003WO2003065004A2 Enzyme activation protease assay
08/07/2003WO2003064666A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003WO2003064665A2 Viral vector
08/07/2003WO2003064649A1 Promoter expressing foreign gene in root and shoot apex
08/07/2003WO2003064645A1 Novel n-acetylgalactosamine transferase and nucleic acid encoding the same
08/07/2003WO2003064637A1 Method and system for myocardial infarction repair
08/07/2003WO2003064636A1 Separation, preparation and use of medullary hematopoietic stem cell
08/07/2003WO2003064635A1 Method of constructing spheroids, spheroids and spheroid-contianing compositions
08/07/2003WO2003064634A1 Liquid for frozen storage of primate embryo stem cells and frozen storage method
08/07/2003WO2003064633A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064630A2 Cell culture medium
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064621A2 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064601A2 Adult human olfactory stem cell
08/07/2003WO2003064598A2 Serum-free media for chondrocytes and methods of use thereof
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064586A2 Method and device for cultivating cells in high densities and for obtaining products from said cells
08/07/2003WO2003064496A2 Biodegradable polymer
08/07/2003WO2003064474A1 Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064463A2 Pluripotency determining factors and uses thereof
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063802A2 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
08/07/2003WO2003063801A2 Treatment of tumor cells for use in immunotherapy of cancer
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063581A2 Compositions and methods for increasing animal size and growth rate
08/07/2003WO2003063575A2 Endothelialization of vascular surfaces
08/07/2003WO2003054199A3 Phytases and method for producing these phytases
08/07/2003WO2003052091A8 Growth factor modified protein matrices for tissue engineering
08/07/2003WO2003048375B1 Hybrid glycosylated products and their production and use
08/07/2003WO2003046132A3 Antisense modulation of myd88 expression
08/07/2003WO2003042366A3 A novel saitohin gene and uses of same
08/07/2003WO2003040340A9 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
08/07/2003WO2003035834A3 Compositions and methods for making mutations in cell lines and animals
08/07/2003WO2003024473A3 Retinoid receptor pan-antagonists for stimulating chondrogenesis
08/07/2003WO2003020916A8 Spider silk protein encoding nucleic acids, polypeptides, antibodies and method of use thereof
08/07/2003WO2003018788B1 Improved nitroreductase enzymes
08/07/2003WO2003016516A3 Kinase crystal structures and materials and methods for kinase activation
08/07/2003WO2002092825B1 Retroviral vectors for gene therapy
08/07/2003WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers
08/07/2003WO2002077179A3 Leinamycin biosynthesis gene cluster and its components and their uses
08/07/2003WO2002068615A3 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives
08/07/2003WO2002057457A3 Human proteins 55562 and 21617, and methods of use thereof
08/07/2003WO2002052023A3 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
08/07/2003WO2002050288A9 Neocentromere-based mini-chromosomes or artificial chromosomes
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002045659A9 Novel therapeutics for heart failure and aging
08/07/2003WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
08/07/2003WO2002031121A9 Improvement of endothelial cell-cell cohesion
08/07/2003WO2002020848A3 Gene and sequence variation associated with cancer
08/07/2003WO2002018608A9 Methods for enhancing the efficacy of cancer therapy
08/07/2003WO2002016625A3 Plant polynucleotides encoding prenyl proteases
08/07/2003WO2002016559A3 In vivo animal model of human leukemia
08/07/2003WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003WO2001092578A3 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
08/07/2003US20030150013 Inducing plant somatic embryogenesis in absence of hormones using expression vector coding glucocorticoid and/or estrogen receptors and the regulatory proteins leafy cotyledon 1 (LEC1) and somatic embryogenesis receptor-like kinase (SERK)
08/07/2003US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
08/07/2003US20030149999 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149996 Method for producing polyclonal and monoclonal antibodies
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149241 Nucleotide sequences coding osteogenic protein for induction/differentiation and/or treatment of bone, cartilage and other connective tissue defects; wound healing agents